干细胞之家 - 中国干细胞行业门户第一站

标题: the scientific nomenclature of stem cell biology [打印本页]

作者: yxc    时间: 2011-6-22 21:07     标题: the scientific nomenclature of stem cell biology

Part I  different fields
% _' i0 p' R0 w9 q& @5 N. F    Many of the terms commonly used have  different meanings for different authors in different fields (for example, researchers working in different model organisms), in some / M3 S. F9 Q& G  J5 `  o  u0 ~/ o
cases more restrictive, in some more wide-ranging.
4 q- N+ x) k6 ^5 `0 F( i3 k; V  p" r( o& O) f' ~0 d0 e
   I suggest that we use the following terminology :& l+ W. H; G' N/ H
-  “Dedifferentiation”: the mechanism by which the normal developmental program is reverted in such a way that differentiated  cells give rise to more plastic, earlier progenitors.
' V8 m0 J* G% C, S5 K1 Q* J
  u# |1 ]+ Z( z2 ?7 i3 U-  “Cancer Stem Cells” (CSCs): the cells responsible for the maintenance, propagation, metastasis and relapse of tumors. They posses self-renewal and differentiation capabilities and can give rise to all the cellular types that compose the tumor mass. Also named cancer-maintaining-cells.
0 J8 g& j" D9 G7 n
. H9 c+ q& M; O, j( z9 N-  “Transdifferentiation” designs the direct conversion (reprogramming) of a differentiated cell type into another different mature cell, without the need of
9 z( s4 U2 u( W, M! W8 Cdedifferentiating to earlier developmental  stages; it usually involves the passage through cellular intermediates that are non-physiological and share markers that are
( P  V9 q, }- [+ Q% N7 w- mnormally mutually exclusive, corresponding to the initiating and the final cell. As we will discuss later, induced pluripotency would be a particular case of transdifferentiation, rather than being a dedifferentiation process, due to the existence of those non-physiological intermediates.  
0 G7 O! J6 z. Q6 y) B( ^  t
% ~3 |/ M2 C2 L" S- @-  “Commitment”: the point of no return in physiological development, where the cell irreversibly enters a specific differentiation program. For a stem cell, it implies the loss of self-renewal.
/ K  Y! X* u; s' }) B4 ~/ S7 l% Y% o* a# S/ g
-  “Epigenetic”: the inheritance of patterns of gene expression, without affecting the genetic code itself. In other words, the inheritance that is not codified in the DNA sequence. From the molecular point of view, it designs all the chromatin modifications that establish (and determine the propagation of) the different possible patterns of 1 A( A2 U; v/ {3 ^9 T
gene expression of a given, unique genome.
" J6 }5 N: D9 t% H- f5 t! J6 {2 A8 O4 |5 F7 I/ ^) x. e6 ]
-  “Reprogramming”: from the cellular point  of view, the natural or experimentally-induced alteration of the differentiation program of a given cell. From the molecular point of view, all the molecular changes (i.e., epigenetic) that take place in a cell that is changing its identity. Dedifferentiation  and transdifferentiation are types of 6 k: [/ ~8 b- ~7 X
reprogramming, usually experimentally-induced. Oncogenesis is also a form of reprogramming, in this case one that spontaneously happens in nature. - a2 D3 c! Y) H: c% g+ C; d
( }1 h" W+ W7 @- r
-  “Cancer cell-of-origin”: the normal cell that first suffers the oncogenic hit and initiates the tumoral process. It is usually the one giving rise to the CSC. It can be either a differentiated cell or a stem/progenitor cell.
作者: ljs    时间: 2011-6-23 10:51

这个是谁提出来的?他的权威性在哪里?依据是什么?请楼主说明,否则这几个定义没有信服力。
作者: 细胞海洋    时间: 2011-6-23 21:23

回复 yxc 的帖子
* \2 f! c1 J% P$ m( R. U/ v5 ^
/ D# A% n3 v/ `8 O说明一下 是原创还是转载?
作者: yxc    时间: 2011-6-24 23:03

原文出自书籍Cancer Stem Cells Theories and Practice中的片段page5) V6 W. J& V: x
本书主编Stanley Shostak,Published by InTech,Janeza Trdine 9, 51000 Rijeka, Croatia,Copyright © 2011 InTech
4 G/ Z# o& D- X第一章5 O0 F6 e- S) }
The Dark Side of Cellular Plasticity:8 l2 f8 a- l! L" k+ v) A6 ?
Stem Cells in Development and Cancer
) U4 b, Y5 m( W6 k作者为:1Fernando Abollo-Jimenez1,
6 z) a4 {! J- r*, Elena Campos-Sanchez2,
* \3 v+ l+ v9 C. X/ w*, Ana Sagrera3,
) ~' f8 s) C. E3 T: {7 |*,! N% \& J& U' w% X/ D9 b
Maria Eugenia Muñoz4, Ana Isabel Galan4,
% T" _- }2 H$ x+ Z6 C$ tRafael Jimenez4 and Cesar Cobaleda2,4# r4 X- w  s7 _* x# J* g' [4 B6 y2 [
1Experimental Therapeutics and Translational Oncology Program;7 O+ q6 r3 H% K+ L9 v+ Y* z
Instituto de Biología Molecular y Celular del Cáncer;
) \, u3 V' f' J$ X( D; kCSIC/Universidad de Salamanca;
. d3 \6 d  s, w1 m" V" {  yCampus M. Unamuno s/n; Salamanca- M8 ^; ^' S$ V& O, A" ~; t
2Centro de Biología Molecular "Severo Ochoa,
# y5 m$ `) h. |+ l/ g7 F"Consejo Superior de Investigaciones Científicas-Universidad/ Q7 x* @7 U5 B7 @4 D# H6 [
Autónoma de Madrid, C/Nicolás Cabrera 1,: F. F2 U( S% f6 g$ M
Universidad Autónoma, Cantoblanco, 28049 Madrid
/ M6 J3 f/ t5 b3Estacion de Atocha, 1, 28740 Colmenar Viejo, Madrid3 V9 |$ B- G6 \
4Departamento de Fisiología y Farmacología,
1 a* q) C) V3 }. v. X  E! b) oUniversidad de Salamanca, Edificio Departamental,
7 w4 B$ `9 k3 Y" I6 r; |Campus Unamuno s/n, 37007-SALAMANCA,0 Z! I+ J" v" E+ H
Spain




欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/) Powered by Discuz! X1.5